Lorlatinib - Pfizer
At a glance
- Drug Originator Pfizer
- Drug Licenced by CStone Pharmaceuticals
- Drug Class Antineoplastics; Aza compounds; Benzoxazines; Nitriles; Pyrazoles; Pyridines; Small molecules
- Mechanism of Action Anaplastic lymphoma kinase inhibitors; ROS1 protein inhibitors
- USA Patent Applicants PFIZER
- USA Patents 5
- NDAs 1
- International Patents 113
- Patent Applications 68
Table of Contents

Disclaimer